Skip to content
Biodatica
Start free

BeiGene

Orlando, Florida

OncologyPhase IIListed · ONC

This company trades under its own ticker, so it sits outside Biodatica’s pre-ticker window. The record stays here because its filings are real, but the feed leaves listed companies out unless you ask for them.

Compare Sign in to watch

What changed

Phase II trial registered: A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid Arthritis

7w agoTrial registeredMay 28, 2026Source filing (opens the source filing in a new tab)

Momentum

80no change

Momentum 80 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase II

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    PHASE2 registered

    Aug 21, 2025

    Rheumatoid Arthritis · TERMINATED · sponsor: BeiGene · A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid Arthritis

    ClinicalTrials.gov · NCT07100938 (opens the source filing in a new tab)

  2. Trial

    PHASE2 registered

    Oct 23, 2023

    Non-Small Cell Lung Cancer · COMPLETED · sponsor: BeiGene · A Study of Gimistotug (BGB-A445) in Combination With Other Investigational Agents in Participants With Non-Small Cell Lung Cancer

    ClinicalTrials.gov · NCT06029127 (opens the source filing in a new tab)

  3. Trial

    PHASE1 registered

    Aug 21, 2023

    Advanced Solid Tumor, Metastatic Solid Tumor, Solid Tumor · TERMINATED · sponsor: BeiGene · BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors

    ClinicalTrials.gov · NCT05935098 (opens the source filing in a new tab)

  4. Trial

    PHASE1 registered

    Jul 19, 2023

    Advanced Solid Tumors · TERMINATED · sponsor: BeiGene · A Study of BGB-30813 Alone or in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors

    ClinicalTrials.gov · NCT05904496 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources